- Home
- KRKR vs PHIO Comparison
KRKR vs PHIO Comparison
Compare KRKR & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- PHIO
- Stock Information
- Founded
- KRKR 2010
- PHIO 2011
- Country
- KRKR China
- PHIO United States
- Employees
- KRKR N/A
- PHIO N/A
- Industry
- KRKR Business Services
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- KRKR Consumer Discretionary
- PHIO Health Care
- Exchange
- KRKR Nasdaq
- PHIO Nasdaq
- Market Cap
- KRKR 12.2M
- PHIO 13.5M
- IPO Year
- KRKR 2019
- PHIO N/A
- Fundamental
- Price
- KRKR $5.59
- PHIO $2.10
- Analyst Decision
- KRKR
- PHIO Strong Buy
- Analyst Count
- KRKR 0
- PHIO 3
- Target Price
- KRKR N/A
- PHIO $10.67
- AVG Volume (30 Days)
- KRKR 22.9K
- PHIO 136.6K
- Earning Date
- KRKR 09-26-2025
- PHIO 11-13-2025
- Dividend Yield
- KRKR N/A
- PHIO N/A
- EPS Growth
- KRKR N/A
- PHIO N/A
- EPS
- KRKR N/A
- PHIO N/A
- Revenue
- KRKR $30,966,526.00
- PHIO N/A
- Revenue This Year
- KRKR $182.55
- PHIO N/A
- Revenue Next Year
- KRKR N/A
- PHIO N/A
- P/E Ratio
- KRKR N/A
- PHIO N/A
- Revenue Growth
- KRKR N/A
- PHIO N/A
- 52 Week Low
- KRKR $2.76
- PHIO $0.97
- 52 Week High
- KRKR $21.36
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- KRKR 35.17
- PHIO 40.80
- Support Level
- KRKR $5.93
- PHIO $2.07
- Resistance Level
- KRKR $6.32
- PHIO $2.45
- Average True Range (ATR)
- KRKR 0.32
- PHIO 0.12
- MACD
- KRKR -0.22
- PHIO -0.03
- Stochastic Oscillator
- KRKR 0.24
- PHIO 4.06
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.